Taku Kouro
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP.
Journal: Frontiers in immunology
Published: March 17, 2026
Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinoma.
Journal: Frontiers in immunology
Published: October 21, 2025
Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.
Journal: Breast cancer research : BCR
Published: October 13, 2025
Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: July 15, 2025
Mechanistic insights into the limited function of CAR-T cells in solid tumors and potential solutions.
Journal: International immunopharmacology
Published: April 17, 2025
Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer.
Journal: Frontiers in immunology
Published: November 01, 2024
Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequence.
Journal: Frontiers in immunology
Published: September 27, 2024
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Journal: Biomedicines
Published: July 04, 2024
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation.
Journal: Computational and structural biotechnology journal
Published: November 02, 2023
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.
Journal: Frontiers in cell and developmental biology
Published: October 20, 2023
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Journal: International journal of clinical oncology
Published: September 28, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma.
Journal: Frontiers in pharmacology
Published: July 31, 2023
Last Updated: 09/26/2026